This is not the most recent version of the article. View current version (8 DEC 2010)

Intervention Protocol

Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems

  1. Anitha Mukundan1,*,
  2. Guy Faulkner2,
  3. Tony Cohn3,
  4. Gary Remington4

Editorial Group: Cochrane Schizophrenia Group

Published Online: 18 JUL 2007

DOI: 10.1002/14651858.CD006629


How to Cite

Mukundan A, Faulkner G, Cohn T, Remington G. Antipsychotic switching for people with schizophrenia who have neuroleptic-induced weight or metabolic problems (Protocol). Cochrane Database of Systematic Reviews 2007, Issue 3. Art. No.: CD006629. DOI: 10.1002/14651858.CD006629.

Author Information

  1. 1

    Yorkshire Deanery, General Adult Psychiatry, Bradford, UK

  2. 2

    University of Toronto, Toronto, Canada

  3. 3

    Centre for Addiction and Mental Health, Schizophrenia Program and MAPS, Toronto, Ontario, Canada

  4. 4

    University of Toronto, Centre for Addiction and Mental Health, Toronto, Ontario, Canada

*Anitha Mukundan, General Adult Psychiatry, Yorkshire Deanery, 3 Strafford Way, Apperley Bridge, Bradford, BD10 0UT, UK. an5mu@yahoo.co.uk.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 18 JUL 2007

SEARCH

This is not the most recent version of the article. View current version (08 DEC 2010)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To determine the effects of antipsychotic medication switching as a strategy for reducing or preventing weight gain in people with schizophrenia who have neuroleptic induced weight or metabolic problems.